184 related articles for article (PubMed ID: 9826467)
1. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen.
Kim SJ; Bae SN; Kim JH; Kim CJ; Jung JK
Gynecol Oncol; 1998 Nov; 71(2):247-53. PubMed ID: 9826467
[TBL] [Abstract][Full Text] [Related]
2. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
[TBL] [Abstract][Full Text] [Related]
3. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
4. Management of resistant gestational trophoblastic tumors.
Newlands ES; Bower M; Holden L; Short D; Seckl MJ; Rustin GJ; Begent RH; Bagshawe KD
J Reprod Med; 1998 Feb; 43(2):111-8. PubMed ID: 9513872
[TBL] [Abstract][Full Text] [Related]
5. [Gestational trophoblastic tumors--a report of experiences].
Ebeling K; Schönborn I; Johannsmeyer D
Zentralbl Gynakol; 1995; 117(5):237-42. PubMed ID: 7540787
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors and staging in gestational trophoblastic tumor.
Soper JT; Evans AC; Conaway MR; Clarke-Pearson DL; Berchuck A; Hammond CB
Obstet Gynecol; 1994 Dec; 84(6):969-73. PubMed ID: 7970479
[TBL] [Abstract][Full Text] [Related]
7. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
Soper JT; Clarke-Pearson D; Hammond CB
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
[TBL] [Abstract][Full Text] [Related]
8. Placental site trophoblastic tumor: an overview.
Bonazzi C; Urso M; Dell'Anna T; Sacco S; Buda A; Cantú MG
J Reprod Med; 2004 Aug; 49(8):585-8. PubMed ID: 15457847
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
Wang S; An R; Han X; Zhu K; Xue Y
Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of staging and prognostic scoring system for malignant trophoblastic neoplasia].
Wang YX; Zhang X; Guan YL; Jang AY; Long ZQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):87-90. PubMed ID: 15840285
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of prognostic factors in high risk gestational trophoblastic disease with respect to remission and recurrence].
Matsui H; Kobayashi O; Takamizawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):131-7. PubMed ID: 1849542
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
[TBL] [Abstract][Full Text] [Related]
13. The management of gestational trophoblastic tumors with etoposide, methotrexate, and actinomycin D.
Soto-Wright V; Goldstein DP; Bernstein MR; Berkowitz RS
Gynecol Oncol; 1997 Jan; 64(1):156-9. PubMed ID: 8995566
[TBL] [Abstract][Full Text] [Related]
14. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
Ayhan A; Yapar EG; Deren O; Kişnişçi H
J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
[TBL] [Abstract][Full Text] [Related]
15. High-risk metastatic gestational trophoblastic disease.
Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and management of gestational trophoblastic tumor with liver metastases].
Xiang Y; Yang X; Yang N; Chen C; Cao T; Song H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):41-3. PubMed ID: 12903491
[TBL] [Abstract][Full Text] [Related]
17. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT -25 years experiences of KRI-TRD.
Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-S96. PubMed ID: 29645247
[TBL] [Abstract][Full Text] [Related]
18. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985.
DuBeshter B; Berkowitz RS; Goldstein DP; Cramer DW; Bernstein MR
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):390-5. PubMed ID: 3029641
[TBL] [Abstract][Full Text] [Related]
19. Salvage combination chemotherapy with 5-fluorouracil and actinomycin D for patients with refractory, high-risk gestational trophoblastic tumors.
Matsui H; Suzuka K; Iitsuka Y; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
Cancer; 2002 Sep; 95(5):1051-4. PubMed ID: 12209690
[TBL] [Abstract][Full Text] [Related]
20. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]